November 17, 2011 at 07:42PM FDA Approves First Drug to Treat Cushing’s Disease in Horses

The Food and Drug Administration announced today the approval of Prascend (pergolide mesylate) for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID or Equine Cushing’s disease) in horses



via Pet Health RSS Feed http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm280401.htm